Kyron.bio

Kyron.bio is a biotechnology company pioneering precision glycan engineering to develop safer and more effective therapeutics.

Its proprietary platform enables precise control over sugar molecules found on the surface of therapeutic proteins, unlocking new possibilities in antibody design and drug development. By improving the efficacy and safety of biologic medicines, Kyron.bio aims to advance treatments for diseases such as cancer and autoimmune disorders.